Pharmaceutical applications of ion-exchange resins

Journal of Chemical Education

Volumn 82, Issue 4, 2005, Pages 575-587

  Elder, David P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; MEDICINE; PHYSICAL CHEMISTRY;

DRUG STABILIZATION; PHARMACEUTICAL EXCIPIENTS; TASTE MASKING AGENTS;

ION EXCHANGE RESINS;

EID: 17244367844     PISSN: 00219584     EISSN: None     Source Type: Journal    
DOI: 10.1021/ed082p575     Document Type: Article

References (76)

1. Anonymous. In Ion Exchange and Polymeric Adsorption Technology in Medicine, Nutrition, and the Pharmaceutical Industry; Rohm and Haas: Philadephia, PA, 1997.
2. Amberlite is a trade mark of the Rohm and Haas companies. http://www. rohmhaas.com/ (accessed Nov 2004).
3. Kunin, K. In Amber-hi-lites. Fifty years of Ion-Exchange Technology Rohm and Haas: Philadephia, PA, 1996.
4. Wallwork, S. C. In Physical Chemistry for Students of Pharmacy and Biology; Longmans, Green and Co.: New York, 1956; p 253.
5. Anand, V.; Kandarapu, R.; Garg, S. Drug-Discovery-Today 2001 6, 905-914.
6. Irwin, W. J.; Belaid, K. A. Drug Dev. Ind. Pharm. 1987, 13, 2017-2031.
7. Bouchard, E. F.; Friedman, I. J.; Taylor, R. J. Vitamin B12 Products andPpreparation Thereof. U.S. Patent 2,830,933, 1958.
8. Ju, R. G.; Myung, L. K.; Young, K. E.; Hyun, L. C.; Joo, H. W. Yakhak Hoeeji 1994, 38, 250-264.
9. Galat, A. Stabilisierte Aspirin-Derivative. German Patent P2200953, 1972.
10. Anonymous. Pharmaceutical Compositions and a Process for the Manufacture Thereof. Hoffman La Roche, British Pat. No. 1101366, 1968.
11. Irwin, W. J.; Machale, R.; Watts, P. J. Drug Dev. Ind. Pharm. 1990, 6, 883-898.
12. Hughes, L. In New Uses of Ion Exchange Resins in Pharmaceutical Formulation; Rohm and Haas: Philadephia, PA, 2002.
13. Kanig, J. L.; Rudnic, E. M. Pharm. Tech. 1984, 8, 50-63.
14. Bolhuis, G. K.; Smallenbroek, A. J.; Lerk, C. F. J. Pharm. Sci. 1981, 70, 1328-1330.
15. Lerk, C. F.; Bolhuis, G. K.; Smallenbroek, A. J.; Zuurman, K. Pharm. Acta. Helv. 1982, 57, 282-286.
16. Khan, K. A.; Rhodes, C. T. J. Pharm. Sci. 1975, 64, 447.
17. van Kamp, H. V.; Bolhuis, G. K.; Lerk, C. F. Proceedings of the 3rd International Conference on Pharmaceutical Technology Paris, May, 1983; pp 35-40.
18. Gissinger, D.; Stamm, A. Drug Dev. Ind. Pharm. 1980, 6 511.
19. Podczek, F.; Revesz, P. Int. J. Pharm. 1993, 91, 183-193.
20. Shangraw, R. F.; Mitrevej, A.; Shah, M. Pharm. Technol. 1980 4, 49.
21. Fuhrer, C. Wiss Verlagzges. In Leitfaden der Schädlingsbekämpfung; Heinze, K., Ed.; Wissenschaftliche Verlagsgesellschaft: Stuttgart, 1974: pp 58-66.
22. Ringard, J.; Guyot-Hermann, A. M. Drug Dev. Ind. Pharm. 1978 2, 36.
23. Robertson, M. I. Int. J. Pharm. 1999, 187, 273-276.
24. van Abbe, N. J.; Rees, J. T. J. Am. Pharm. Assoc. 1958, 7 487-489.
25. Khan, K. A.; Rhodes, C. T. Can. J. Pharm. Sci. 1973, 8 77-80.
26. Rubinstein, M. H. In Pharmaceutics: The Science Of Dosage Form Design Aulton M. E., Ed.; Churchill Livingstone: London, 1988; Chapter 18, p 305.
27. Andersen, O.; Zweidorff, O. K.; Hjelde, T.; Rodland, E. A. Tiddskrift for Den Norske Laegeforening through Ovid 1995, 115, 947-949.
28. Schumacher, G. E. In Perspectives in Clinical Pharmacology; Francke, D. E., Whitney, H. A., Eds.: American Pharmacists Association: Washington DC, 1972; p 368.
29. Gowan, W. G.; Bruce, W. E. Aliphatic Esters as a Solventless Coating for Pharmaceuticals. Canadian Patent 2,082,137, 1993.
30. Fu, Lu M.-Y. Pharm. Res. 1991, 8, 706-712.
31. Anonymous. In The Merck Index: Encyclopaedia of Chemical Drugs and Biologicals, 10th ed.: Merck: Rahway, NJ, 1983; p 1165.
32. Anonymous. In Handbook of Pharmaceutical Excipients, 3rd ed.; Kibbe, A. H., Ed.; The Pharmaceutical Press: London, 2000.
33. Alan, H. R.; Christopher, F. L.; Herbert, H. T.; Eric, S. E. Taste-Masked Buflomedil Preparation. European Patent EP0501763, 1992.
34. Lu, M. F.; Borodkin, S.; Woodard, L.; Li, P.; Disener, C.; Hernandez, L.; Vadere, M. Pharm. Res. 1991, 8, 706-712.
35. Douglas, S. J.; Bird, F. R. Drug Adsorbates. U.S. Patent 5,219,563, 1992.
36. Spross, B.; Ryde, M.; Nystrom, B. Acta. Pharma. Suecica. 1965 2, 1-12.
37. Lange, P. M. Ion Exchange Resins Loaded with Quinolonecarboxylic Acid Derivatives, for Taste Masking in Feed. U.S. Patent 5,152,986, 1992.
38. Elder, D. P.; Park, A.; Patel, P.; Marzolini, M. In Ion Exchange at the Millennium; Greig, J. A., Ed.; Imperial College Press: London, 2000; pp 306-313.
39. Billany, M. R. In Suspensions in Pharmaceutics: The Science of Dosage Form Design; Aulton, M. E., Ed.; Churchill Livingstone Press: London, 2000; Chapter 15, p 271.
40. Keating, J. W. Pharmaceutical Preparations Comprising Cation Exchange Resin Adsorption Compounds and Treatment Therewith. U.S. Patent 2,990,332, 1964.
41. Lordi, N. G. In The Theory and Practice of Industrial Pharmacy, 3rd ed.; Lachman, L., Lierbeman, H. A., Kanig, J. L., Eds.; Lea and Febiger: Philadelphia, PA, 1986; p 450.
42. Kurowski, M. Int. J. Clin. Pharmacol. Ther. 1994, 32, 433-440.
43. Amsel, L. P.; Hinsvark, O. N.; Rotenberg, K.; Scheumaker, J. L. Pharm. Technol. 1984, 8, 28-48.
44. Motycka, S.; Newth, C. J. L.; Nairn, J. G. J. Pharm. Sci. 1985 74, 643-646.
45. Moldenhauer, M. G.; Nairn, J. G. J. Pharm. Sci. 1990, 79 659-666.
46. Schlichting, D. A. J. Pharm. Sci. 1962, 51, 134.
47. Smith, H. A.; Evanson, R. V.; Sperandio, G. J. J. Amer. Pharm. Assoc. 1960, 49, 94-97.
48. Sriwongjanya, M.; Bodmeier, R. Eur. J. Pharm. Biopharm. 1998 46, 321-327.
49. Kogan, P. W.; Rudnic, E. M.; Sesqueira, J. A.; Chaudry, I. A. Sustained Release Oral Suspensions. U.S. Patent 4,999,189, 1991.
50. Lui, Z.; Cheung, R.; Wu, X. Y.; Ballinger, J. R.; Bendayan, R.; Rauth, A. M. J. Controlled Release 2001, 77, 213-224.
51. Hussain, M. A. Pharm. Res. 1989, 6, 49-52.
52. Raghunathan, Y.; Amsel, I.; Hinsvark, O.; Bryant, W. J. Pharm. Sci. 1981, 70, 379-384.
53. Winters, J. C. J. Soc. Cosmet. Chem. 1956, 7, 3.
54. Ward, J. B.; Sperandio, G. J. paper presented to American Pharmaceutical Association, 113th Annual Meeting, Dallas, TX, 1966.
55. Percival, R. W. Am. Perfumer 1962, 77, 39-41.
56. Conaghey, O. M. Int. J. Pharm. 1998, 170, 225-237.
57. Jaskari, T. J. Controlled Release 2000, 67, 179-190.
58. Colestyramine resin, colestyramine for oral suspension, colestipol hydrochloride, colestipol hydrochloride for oral suspension, United States Pharmacopeia, 25th ed.; USP Convention Inc.: Washington, 2002,; pp 413-414, 414, 473-474, 474, respectively.
59. Kaur, I. P.; Kanwar, M. Drug Dev. Ind. Pharmacy 2002, 28 473-493.
60. Rajni, J.; Gan, O.; Ali, Y.; Rodstrom, R.; Hancock, S. J. Ocul. Pharmacol. 1994, 10, 57-67.
61. Illum, L. Nasal Drug Delivery Composition Containing Nicotine. U.S. Patent 5,935,604, 1996.
62. Mizushima, Y. Medicaments for Nasal Administration. U.S. Patent 5,942,242, 1996.
63. Davis, S. S.; Norring-Christensen, F.; Khosla, R.; Feely, L. C. J. Pharm. Pharmacol. 1988, 40, 205-207.
64. Davis, S. S.; Hardy, J. G.; Taylor, M. J.; Whalley, D. R.; Wilson, C. G. Int. J. Pharm. 1984, 21, 167-177.
65. Adkin, D. A.; Davis, S. S.; Sparrow, R. A.; Wilding, I. R. J. Controlled Release 1993, 23, 147-156.
66. Wilding, I. R.; Davis, S. S.; Steed, K. P.; Sparrow, R. A.; Westrup, J.; Hempenstall, J. M. Int. J. Pharm. 1994, 101, 263-268
67. Borodkin, S.; Yunker, M. H. J. Pharm. Sci. 1970, 59, 481-486.
68. Nash, R. A. In Pharmaceutical Suspensions in Pharmaceutical Dosage Forms: Disperse Systems, 2nd ed.; Lieberman, H. A., Rieger, M. M., Banker, G. S., Eds.; Marcel Dekker Press: New York, 1996; Chapter 1, Vol. 2, p 30.
69. Weller, P. J. In Sodium Benzoate Monograph, Handbook of Pharmaceutical Excipients, 3rd ed.; Kibbe, A.H., Ed.; The Pharmaceuitcal Press: London, 2000; pp 471-473.
70. Rieger, M. M. In Methylparaben and Propylparaben Monographs, Handbook of Pharmaceutical Excipients, 3rd ed.; Kibbe, A. H., Ed.; The Pharmaceuitcal Press: London, 2000; pp 340-344, 450-453.
71. Patel, N.; Kostenbauder H. B. J. Am. Pharm. Assoc. (Sci.) 1976 47, 289-293.
72. Polacrilin Potassium. United States Pharmacopeia, 25th ed.; USP Convention Inc.: Washington, DC, 2002; p 2592.
73. Anion Exchange Resin. United States Pharmacopeia, 25th ed.; USP Convention Inc.: Washington, DC, 2002; p 2283.
74. Cation Exchange Resin. United States Pharmacopeia, 25th ed.; USP Convention Inc.: Washington, DC, 2002; p 2291.
75. Palmieri, A. In Polacrilin Potassium Monograph, Handbook of Pharmaceutical Excipients, 3rd ed.; Kibbe, A. H., Ed.; The Pharmaceuitcal Press: London, 2000; pp 383-385.
76. Rudnic, E. M.; Rhodes, C. T.; Welch, S.; Bernardo, P. Drug Dev. Ind. Pharm. 1982, 8, 87-109.